Skip to content

COVID-19 Infection in Patients With Chronic Pulmonary Diseases.

COVID-19 Infection in Patients With Chronic Pulmonary Diseases.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05087199
Enrollment
100
Registered
2021-10-21
Start date
2021-11-01
Completion date
2022-07-30
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pulmonary Disease, COVID-19

Keywords

COVID-19, Chronic pulmonary disease

Brief summary

This study aims to assess the clinical presentation, radiological patterns and outcome of COVID-19 infection in patients with chronic pulmonary disease. Inter-relationship between the severity of COVID-19 infection and chronic pulmonary diseases.

Detailed description

The COVID-19 pandemic has led to many difficulties with the diagnosis and routine management of chronic pulmonary diseases such as COPD, Bronchial asthma, ILD and Bronchiectasis as well as raising concerns about the management and outcomes for patients with these diseases who develop COVID-19. Although there is conflicting evidence on whether patients with chronic respiratory diseases are more susceptible to COVID-19, these patients exhibit a more severe presentation and higher mortality compared with those without chronic respiratory diseases.

Interventions

DIAGNOSTIC_TESTRt-PCR.

Nasopharyngeal swab for Rt-PCR for COVID-19

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
16 Years to 100 Years

Inclusion criteria

* Subjects with confirmed diagnosis of COVID-19 infection by: RT-PCR And Chest Computed tomography and laboratoty investigations. Patients with chronic chest disease including (COPD, bronchial asthma, ILD, bronchiectasis).

Exclusion criteria

* Those who are diagnosed with viral pneumonia caused by viruses other than COVID-19. Those who are not confirmed to be COVID-19 with PCR or by radiological and laboratory investigations.

Design outcomes

Primary

MeasureTime frame
Effect of COVID-19 on patients with chronic pulmonary diseases2 weeks after patient confirmation of infection by COVID-19

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026